Chief Financial Officer
Jami Rubin has 30 years of experience in the biopharma industry as a finance executive, equity analyst, investment banker, board member, and venture partner.
Prior to Boundless Bio, she served as Chief Financial Officer of EQRx where she built a world-class finance organization and led a transformational go public process that raised $1.35 billion. Previous to EQRx, Jami was a Partner at PJT Partners, a global advisory-focused investment bank, where she provided strategic M&A, corporate finance, and capital-raising guidance for biotech and pharmaceutical companies. She also served as a Partner at Goldman Sachs where she led the healthcare business unit and ranked as a top pharmaceutical industry analyst. Earlier in her career, Jami was Managing Director at Morgan Stanley where she covered large cap and specialty pharma. Jami is a Venture Partner at ARCH Venture Partners and a member of the Board of Directors and audit committee chairperson of Relay Therapeutics.
Jami holds a B.A. in History from Vassar College.